26 results
treatment diagnosis idsa opportunistic prevention differential medications classification comparison criticalcare diabetes dm2 endocrinology inotropes mycobacterium nephrology rhabdomyolysis shock tuberculosis vasopressors
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
Summary table of ... medical diagrams, tables ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Summary of characteristics of Antianginal Drugs DRUG CLASS, ADVERSE EFFECTS AND DRUG INTERACTIONS #Antianginal #Medications #Cardiology
Summary of characteristics ... Medications #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. #pharmacology
Summary table of ... #pharmacology #dm2 ... #medications #overview ... #management #comparison
Vasopressors and Inotropes - Pharmacology Summary Vasopressors Phenylephrine (alpha-1) • Increases BP, SVR • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... • Higher doses cause ... cAMP/cGMP • Causes ... #Summary #management
Vasopressors Table Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Resistance, Main Uses ... Vasopressors #Properties #Table ... #Pharmacology # ... Effect #Management
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... not definitively cause ... #Summary #DM2 #
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... 100 cells/mm3 g/mL ... Treating Acute Infection ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Ferritin >1000 ng/ml ... sIL-2R >2400 Ul/ml ... Drugs, Unknown cause ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
Bacterial Enteric Infections ... • In rare cases ... if MIC<0.12 ug/ml ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
chew, or crush tablet ... suspension 4–6 mL ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
No results found for "MCL pharmacology table causes management infections hivaids summary overview"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #pharmacology #table #causes #management #infections #hivaids #summary #overview